Skip to content

Quality of Life After Surgery for Pancreatic Carcinoma

Quality of Life After Surgery for Pancreatic Carcinoma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02175992
Enrollment
300
Registered
2014-06-26
Start date
2012-03-31
Completion date
2017-06-30
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Suspected for a Pancreatic (Pre-)Malignancy

Brief summary

Pancreatic cancer has a high mortality rate. Patients with an intended curative resection show a median survival of 17-23 months. Therefore, quality of life is very important in this patient group. In this study, the effect of pancreatic surgery on quality of life is measured.

Interventions

None listed

Sponsors

UMC Utrecht
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a suspected pancreatic malignancy * eligible for surgery with curative intent * being able to complete questionnaires in Dutch * age \>=18 years

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Health-related quality of life2 yearsTo assess the influence of pancreatic surgery for patients with a pancreatic malignancy on health-related quality of life

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026